Related Experiment Video
Updated: Jun 15, 2026
10:25
"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
[Liver hemosiderosis study in chronic viral hepatitis]
Camelia Cojocariu1, Anca Trifan, Maria Sultana Mihailovici
1Disciplina de Semiologie Medicală, Facultatea de Medicină, Universitatea de Medicină si Farmacie Gr.T. Popa Iasi.
Summary
Nearly a quarter of chronic viral hepatitis cases show liver iron deposits, a condition known as hepatic hemosiderosis. This condition is more prevalent in men and often presents with low to medium iron overload.
Area of Science:
- Hepatology
- Pathology
- Gastroenterology
Context:
- Chronic viral hepatitis is a significant global health concern.
- Liver iron deposits (hepatic hemosiderosis) are observed in a notable percentage of patients with chronic viral hepatitis.
- Histopathological examination is crucial for diagnosing liver conditions and assessing iron overload.
Purpose:
- To determine the incidence of hepatic hemosiderosis in patients with chronic viral hepatitis.
- To analyze the localization and degree of iron deposits in liver biopsies.
- To investigate potential influencing factors such as gender, age, and alcoholic etiology.
Summary:
- A study of 549 liver biopsy specimens revealed that 22.8% of chronic viral hepatitis cases exhibited positive iron staining.
- Hepatic hemosiderosis was more common in males and frequently presented as grade 1-2 iron overload.
- Iron deposits were predominantly found in the reticuloendothelial system or mixedly with hepatocytes, with higher incidence in Hepatitis B compared to Hepatitis C.
Impact:
- Findings indicate that hepatic hemosiderosis is a common comorbidity in chronic viral hepatitis, particularly in men aged 30-50.
- The study highlights that alcoholic etiology does not significantly influence hemosiderosis incidence in viral hepatitis.
- Understanding the prevalence and characteristics of hemosiderosis aids in patient management and risk stratification.
Related Concept Videos
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...